Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2020 / Cilt: 54 - Sayı: 2

Effects of Ankylosing Spondylitis on Erectile Function

Pages
188–192
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ED risk factors wereshown as disease activity and psychological status.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Ankylosing spondylitis (AS), which is a chronic rheumatologic disorder, may be associated with erectile dysfunction(ED).
📊
Key Findings & Data:Participants in both groups filled in the IIEF-5 (International Index of Erectile Function),Beck Depression Index (BDI) and Beck Anxiety Index (BAI) questionnaires, whereas patients with AS additionally filled in BathAnkylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath AnkylosingSpondylitis Metrological Index (BASMI) and Ankylosing Spondylitis Quality of Life (ASQoL) questionnaires.
💡
Conclusion & Impact:ED risk factors wereshown as disease activity and psychological status.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Ankylosing spondylitis (AS), which is a chronic rheumatologic disorder, may be associated with erectile dysfunction(ED). This study aims to investigate the incidence of erectile dysfunction in patients with AS with a control group and to investigatethe risk factors for ED.Methods: All demographic data were recorded. Participants in both groups filled in the IIEF-5 (International Index of Erectile Function),Beck Depression Index (BDI) and Beck Anxiety Index (BAI) questionnaires, whereas patients with AS additionally filled in BathAnkylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath AnkylosingSpondylitis Metrological Index (BASMI) and Ankylosing Spondylitis Quality of Life (ASQoL) questionnaires. Patients were comparedconcerning erectile function and predictive factors. Fifty patients with the AS diagnosis and fifty healthy males were included inthis study.Results: ED of all degrees was present in 38% and 30% of males in the AS group and control group, respectively, with no statisticaldifference. However, the mean IIEF-EF domain score of the AS group (22.3±7.0) was significantly lower than the control group(25.7±4.3) (p=0.004). In addition, BDI and BAI scores were significantly higher in the AS group. When we have divided patients inthe AS group into two, according to the presence or absence of the ED, the mean IIEF-EF domain score of patients with ED waslower than AS patients without ED. No difference was detected in both groups concerning age and the duration of the disease. Patientswho had ED in the AS group had significantly higher scores in BASDAI, BASFI, depression and anxiety; however, no significantdifference was detected among groups regarding BASMI scores.Mean IIEF score was lower in patients with AS, and this had a negative correlation with BASDAI, BASFI, ASQoL, BDI and BAI scores.Conclusion: Erectile function scores were slightly lower in the AS group than the control group in our study. ED risk factors wereshown as disease activity and psychological status.

🔖

Cite This Article

ERDEM, İ. H., ORTAÇ, M., SALABAŞ, E. (2020). Effects of Ankylosing Spondylitis on Erectile Function. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 54 - Sayı: 2, 188–192. https://ajindex.com/articles/358567

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res (Hoboken) 2013;65:1299–306
  2. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379–90
  3. Tristano AG. The impact of rheumatic diseases on sexual function. Rheumatol Int 2009;29:853–60
  4. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, et al; EAU. EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006;49:806–15
  5. Liu YF, Dong H, Chen Z, Wang YU, Tu SH. Impact of ankylosing spondylitis on sexual function: A systematic review and metaanalysis. Exp Ther Med 2015;9:1501–7
  6. Bal S, Bal K, Turan Y, Deniz G, Gürgan A, Berkit IK, Sendur OF. Sexual functions in ankylosing spondylitis. Rheumatol Int 2011;31:889- 94
  7. Fan D, Liu L, Ding N, Liu S, Hu Y, Cai G, et al. Male sexual dysfunction and ankylosing spondylitis: a systematic review and metaanalysis. J Rheumatol 2015;42:252-7
  8. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25:280–4
  9. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281–5
  10. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694–8
  11. Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N. The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 2005;25:612–8
  12. Duruöz MT, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M, et al. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int 2013;33:2717–22
  13. Turunç T, Deveci S, Güvel S, Peşkircioğlu L. The assessment of Turkish validation with 5 question version of International Index of Erectile Function (IIEF-5). Turk J Urol 2007;33:45–9
  14. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional s